Palopegteriparatide

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Hypoparathyroidism Post Thyroidectomy: Prevention, Evaluation, Management, and Application of Recent Guidelines.

Hypoparathyroidism Post Thyroidectomy: Prevention, Evaluation, Management, and Application of Recent Guidelines.

Journal: Thyroid : official journal of the American Thyroid Association

Published: May 22, 2026

Palopegteriparatide Therapy for Hypoparathyroidism: Targeting the PTH Receptor Rouses the Sleeping Skeleton.

Palopegteriparatide Therapy for Hypoparathyroidism: Targeting the PTH Receptor Rouses the Sleeping Skeleton.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: March 30, 2026

Sustained Improvement in Renal Function with Palopegteriparatide in Adults with Chronic Hypoparathyroidism: 2-Year Results from the Phase 3 PaTHway-Trial.

Sustained Improvement in Renal Function with Palopegteriparatide in Adults with Chronic Hypoparathyroidism: 2-Year Results from the Phase 3 PaTHway-Trial.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: January 30, 2026

The key data from the 2025 ESE/ESPE Congress: Chronic hypoparathyroidism in adults.

The key data from the 2025 ESE/ESPE Congress: Chronic hypoparathyroidism in adults.

Journal: Annales d'endocrinologie

Published: January 28, 2026

A novel method for the evaluation of hypercalciuria in individuals with chronic hypoparathyroidism.

A novel method for the evaluation of hypercalciuria in individuals with chronic hypoparathyroidism.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: January 20, 2026

Neural plasticity impairment in chronic post-surgical hypoparathyroidism: a cross-sectional and prospective pilot study.

Neural plasticity impairment in chronic post-surgical hypoparathyroidism: a cross-sectional and prospective pilot study.

Journal: Endocrine connections

Published: January 14, 2026

Treatment of hypoparathyroidism (HypoPT): Position Statement of the Expert Group for Polish Society of Endocrinology - update 2026.

Treatment of hypoparathyroidism (HypoPT): Position Statement of the Expert Group for Polish Society of Endocrinology - update 2026.

Journal: Endokrynologia Polska

Published: January 07, 2026

Acute use of teriparatide and palopegteriparatide in the management of hungry bone syndrome following parathyroidectomy.

Acute use of teriparatide and palopegteriparatide in the management of hungry bone syndrome following parathyroidectomy.

Journal: JCEM case reports

Published: January 07, 2026

Reflections on prevention and treatment of post-thyroidectomy hypoparathyroidism: current management approaches and future prospects.

Reflections on prevention and treatment of post-thyroidectomy hypoparathyroidism: current management approaches and future prospects.

Journal: Frontiers in endocrinology

Published: December 15, 2025

Management of patients with hypoparathyroidism: a Delphi consensus analysis.

Management of patients with hypoparathyroidism: a Delphi consensus analysis.

Journal: Journal of endocrinological investigation

Published: December 11, 2025

Successful transition from rhPTH(1-84) to palopegteriparatide in chronic hypoparathyroidism.

Successful transition from rhPTH(1-84) to palopegteriparatide in chronic hypoparathyroidism.

Journal: JCEM case reports

Published: December 10, 2025

Palopegteriparatide in Japanese adults with hypoparathyroidism: 52-week results from the phase 3 PaTHway Japan trial.

Palopegteriparatide in Japanese adults with hypoparathyroidism: 52-week results from the phase 3 PaTHway Japan trial.

Journal: Endocrine journal

Published: November 19, 2025

Showing 1-12 of 35

Last Updated: 06/30/2026